首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   542篇
  免费   34篇
  国内免费   1篇
耳鼻咽喉   16篇
儿科学   9篇
妇产科学   7篇
基础医学   73篇
口腔科学   65篇
临床医学   29篇
内科学   75篇
皮肤病学   80篇
神经病学   37篇
特种医学   20篇
外科学   33篇
综合类   4篇
预防医学   67篇
眼科学   5篇
药学   42篇
中国医学   5篇
肿瘤学   10篇
  2023年   13篇
  2022年   10篇
  2021年   17篇
  2020年   16篇
  2019年   24篇
  2018年   39篇
  2017年   21篇
  2016年   29篇
  2015年   20篇
  2014年   43篇
  2013年   31篇
  2012年   42篇
  2011年   71篇
  2010年   27篇
  2009年   11篇
  2008年   35篇
  2007年   32篇
  2006年   29篇
  2005年   17篇
  2004年   11篇
  2003年   15篇
  2002年   6篇
  2001年   2篇
  2000年   4篇
  1999年   3篇
  1998年   1篇
  1993年   1篇
  1992年   1篇
  1975年   2篇
  1973年   1篇
  1972年   1篇
  1932年   1篇
  1928年   1篇
排序方式: 共有577条查询结果,搜索用时 0 毫秒
91.
The senescence-accelerated mouse (SAM) is known to be a murine model for accelerated aging. The SAMP8 strain shows age-related deterioration of learning and memory at an earlier age than control mice (SAMR1). In the present study, we investigated the changes in expressions of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the brain of SAMP8. In the hippocampus of 10 months old SAMP8, the expression of IL-1 mRNA was significantly elevated in comparison with that of SAMR1. In both strains of SAMs, increases in IL-1β protein in the brain were observed at 10 months of age compared with 2 and 5 months. The only differences found between the strain in protein levels were at 10 months and were elevations in IL-1β in the hippocampus and hypothalamus, and in TNF-α and IL-6 in the cerebral cortex and the hippocampus in SAMP8 as compared with SAMR1. However, lipopolysaccharide-induced increases in the expression of these cytokines in brain did not differ between SAMP8 and SAMR1. Increases in expression of proinflammatory cytokines in the brain may be involved in the age-related neural dysfunction and/or learning deficiency in SAMP8.  相似文献   
92.
93.
Heavy metal exposure is associated with cardiovascular diseases such as myocardial infarction (MI). Vascular dysfunction is related to both the causes and the consequences of MI. We investigated whether chronic exposure to low doses of mercury chloride (HgCl2) worsens MI-induced endothelial dysfunction 7 days after MI. Male Wistar rats were divided into four groups: Control (vehicle), HgCl2 (4 weeks of exposure), surgically induced MI and combined HgCl2-MI. Morphological and hemodynamic measurements were used to characterize the MI model 7 days after the insult. Vascular reactivity was evaluated in aortic rings. Chronic HgCl2 exposure did not cause more heart injury than MI alone in terms of the morphological or hemodynamic parameters. Vascular reactivity increased in all groups, but the combination of HgCl2-MI increased the vasorelaxation induced by ACh compared with the HgCl2 and MI groups. Results showed reduced endothelial nitric oxide synthase (eNOS) protein expression in the MI group; increased iNOS activity in the HgCl2-MI group, although without enough magnitude to reverse the reduction in NO bioavailability; and increased phenylephrine response in the HgCl2-MI group due to an increase in ROS production, notably via xanthine oxidase (XO). Results suggest that the combination of 1 month pre-exposure of HgCl2 before MI changed the endothelial generation of oxidative stress induced by mercury exposure from NADPH oxidase pathway to XO (xanthine oxidase)-dependent ROS production.  相似文献   
94.
95.
96.
Adalimumab is a powerful drug used to treat psoriasis, that has been specially designed to mimic normal human molecules, and for this reason it is classed as a ‘biological’ drug. It reduces inflammation by inhibiting the activity of a chemical ‘cytokine’ in the body called ‘tumour necrosis factor alpha’ (TNF-alpha). The aim of this study, from the USA, was to assess long-term safety for patients with psoriasis receiving adalimumab. The authors looked at data from 3727 patients receiving the drug as part of 18 different clinical trials in which adverse events (AEs, meaning unwanted side effects while on the drug) were recorded. Overall, there were 16,536 AEs during 5429.7 patient years (304.6 AEs for every 100 patient years). Patient years (PYs) means the number of patients, multiplied by the amount of time they were included in the study. Most common AEs were nasopharyngitis (a common throat complaint), upper respiratory infection, and headache (23.7, 12.9, and 7.9 AEs per 100 PYs, respectively). Incidence rates for serious infections, tuberculosis, and opportunistic infections were 1.8, 0.3, and 0.02 AEs per 100 PYs, respectively. Incidence of malignancy (cancer) excluding non-melanoma skin cancer (NMSC) was 0.8 AEs per 100 PYs. Incidences of NMSC and melanoma were 0.6 and 0.2 AEs per 100 PYs, respectively. The authors conclude that AE rates remained stable in this analysis of patients with psoriasis receiving adalimumab; no new safety signals (such as increased AEs) were identified compared with earlier studies.  相似文献   
97.
98.
99.
Objective: To identify predictors of misidentification of organic mental disorders and delirium in patients undergoing psychiatric liaison consultation.

Methods: Data were collected at Santa Casa de São Paulo between July of 2009 and March of 2013. We included in our analysis all inpatients for whom the requesting service judged that a psychiatric consultation was required for a possible mental health condition. Outcomes of interest were the instances of misidentification where a condition was initially deemed to be of a psychiatric nature, whereas the final diagnosis by the liaison psychiatric team was of an organic disease or delirium. Our predictors were the clinical specialty of the requesting service, requester and patient characteristics. A series of generalised linear models were used to evaluate misidentification risks.

Results: A total of 947 subjects met our inclusion criteria, 14.6% having a final liaison diagnosis of organic mental disorder and 8.1% of delirium. Older patients were significantly associated with increased risk of misidentification for both organic conditions (OR 3.01 – 95% CI 2.01, 4.5) and delirium (OR 3.92 – 2.4, 6.39).

Conclusions: Educational interventions in general hospitals focused on preventing psychiatric misdiagnosis should target in-hospital services where patients tend to be older.  相似文献   

100.
Abstract: The mechanisms underlying the cardiovascular responses evoked by milonine (i.v.), an alkaloid, were investigated in rats. In normotensive rats, milonine injections produced hypotension and tachycardia, which were attenuated after Nw‐nitro‐l ‐arginine methyl esther (l ‐NAME; 20 mg/kg, i.v.). In phenylephrine (10 μM), pre‐contracted mesenteric artery rings, milonine (10?10 M to 3 × 10?4 M) caused a concentration‐dependent relaxation (EC50 = 1.1 × 10?6 M, Emax = 100 ± 0.0%) and this effect was rightward shifted after either removal of the vascular endothelium (EC50 = 1.6 × 10?5, p < 0.001), or after l ‐NAME 100 μM (EC50 = 6.2 × 10?5, p < 0.001), hydroxocobalamin 30 μM (EC50 = 1.1 × 10?4, p < 0.001) or ODQ 10 μM (EC50 = 1.9 × 10?4p < 0.001). In addition, in rabbit aortic endothelial cells, milonine increased NO3? levels. The relaxant effect induced by milonine was attenuated in the presence of KCl (20 mM), a modulator efflux K+ (EC50 = 1.2 × 10?5, p < 0.001), or different potassium channel blockers such as glibenclamide (10 μM) (EC50 = 6.3 × 10?5, p < 0.001), TEA (1 mM) (EC50 = 2.3 × 10?5 M, n = 6) or Charybdotoxin (0.2 μM) plus apamin (0.2 μM) (EC50 = 3.9 × 10?4 M, n = 7). In addition, pre‐contraction with high extracellular potassium concentration prevented milonine‐induced vasorelaxation (EC50 = 1.0 × 10?4, p < 0.001). Milonine also reduced CaCl2‐induced contraction in Ca2+‐free solution containing KCl (60 mM). In conclusion, using combined functional and biochemical approaches, we demonstrated that the hypotensive and vasorelaxant effects produced by milonine are, at least in part, mediated by the endothelium, likely via nitric oxide release, activation of nitric oxide‐cGMP pathway and opening of K+ channels.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号